PlainRecalls
FDA Drug Low Class III Terminated

Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01

Reported: October 21, 2020 Initiated: September 24, 2020 #D-0034-2021

Product Description

Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01

Reason for Recall

Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

Details

Units Affected
1380 bottles
Distribution
PA and Italy
Location
Gaithersburg, MD

Frequently Asked Questions

What product was recalled?
Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01. Recalled by Leadiant Biosciences, Inc.. Units affected: 1380 bottles.
Why was this product recalled?
Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 21, 2020. Severity: Low. Recall number: D-0034-2021.